Pakistan latest patents query
The latest invention patents collect the data information of Pakistan invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
New process for the synthesis of (7-methoxy-1naphthyl)acetonitrile and applicaton in the synthesis of agomelatine.
UndeterminedPK141178A
Owner:LES LAB SERVIER SA
A pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester of pyrimidyl sulphone amide compound
UndeterminedPK201100179A0
Owner:ASTRAZENECA AB
Method and plant for dedusting a stream of dust-laden gases in a hybrid filter installation
UndeterminedPK201100229A0
Owner:F L SMIDTH & CO AS
Process for the synthesis of molecular imprinted polymer particles or micro beads and product thereof,for selective detoxification of endosulphan, its analogues or derivatives contaminated natural waters.
UndeterminedPK201100097A0
Owner:COUNCIL OF SCI & IND RES
Electrode for electrochemical processes and method for obtaining the same.
ActivePK201100106A0
Owner:INDUSTRIE DE NORA SPA
Derivatives of 1-amino-2 cyclopropylethylboronic acid
UndeterminedPK201100221A0
Owner:MILLENNIUM PHARMACEUTICALS INC
Stabilized formulations containing anti interleukin-6 receptor (il-6r) antibodies
UndeterminedPK201100001A0
Owner:REGENERON PHARMACEUTICALS INC
A Closure for a Container(One action opening device with a cam system for reducing the opening force
UndeterminedPK201100225A0
Owner:TETRA LAVAL HOLDINGS & FINANCE SA
A B-Sitosterol-Poly (ethylene glycol) Methyl Ether Pellet Formulation and Method of Preparation for the Treatment of Liver Cancer
PendingPK202600697A0
Owner:THE UNIV OF LAHORE
Pharmaceutically active disubstituted triazine derivatives
UndeterminedPK201100194A0
Owner:LEAD DISCOVERY CENTER GMBH
Substituted pyrrolidinyl-1h-benzo[d]imidazol-2(3h)-ylidene Cyanamide compound
UndeterminedPK141132A
Owner:ELI LILLY & CO
Estratriene compound comprising heterocyclic bioisostere for the phenolic A ring
UndeterminedPK141083A
Owner:BAYER SCHERING PHARMA AG
A process for making low cost wind turbine electric generators.
UndeterminedPK201100246A0
Owner:DR SUHAIL ZAKI FAROOQUI
A synthetic codon‐optimized G5 gene for broad‐spectrum genetically‐engineered resistance against begomoviruses
UndeterminedPK201100274A0
Owner:NATIONAL INSTITUTE FOR BIOTECHNOLOGY & GENETIC ENGINEERING
Aptamers to beta‐ngf and their uses in treating beta‐ngf mediated diseases and disorders.
UndeterminedPK201100249A0
Owner:SOMALOGIC OPERATING CO INC +1
Method to increase solubility limit of rebaudioside d in an aqueous solution
UndeterminedPK201100081A0
Owner:PEPSICO INC
An improved form of trailer with the hydraulic power to match the steering angles
UndeterminedPK201100220A0
Owner:MR NADEEM ZAFAR MANAGING PARTNER M S CRESCENT TRANSPORT SERVICES
Novel denim cotton / spun polypropylene
UndeterminedPK201100051A0
Owner:MUHAMMAD MUSHTAQ AHAMED MANGAT +2
Composition for ameliorating hypoalbuminemia.
ActivePK201100242A0
Owner:OTSUKA PHARMACEUTICAL FACTORY INC
Sealed package for pourable food products and packaging material for producing sealed packages for pourable food products.
ActivePK201100241A0
Owner:TETRA LAVAL HOLDINGS & FINANCE SA
A novel balloon-expandable stent assembly.
UndeterminedPK201100110A0
Owner:ALVIMEDICA TIBBI URUNLER SANAYI VE DIS TICARET
Fusion Protein Composition Comprising Receptor for Advanced Glycated Endproducts (RAGE) polypeptide
UndeterminedPK141115A
Owner:VTVX HLDG I LLC
A composition comprising a physiologically acceptable salt of (1S,4R) cis-4-[2-amino-6-(cyclopropylamino)-9H purin-9-yl]-2-cyclopentene-1-methanol and (2R,cis)-4-amino-(2-hydroxymethyl-1,3 oxathiolan-5-yl)-(1H)-pyrimidin-2-one
UndeterminedPK201100169A0
Owner:THE WELLCOME FOUND LTD
Crystalline form of an alkoxyimdazol-1-ylmethyl biphenyl carboxylic acid
UndeterminedPK141123A
Owner:THERAVANCE INC
Alginate grafted Hybrid Bio Hydrogel for Simultaneous Removal of Dissolved Contaminants from Wastewater
PendingPK202600715A0
Owner:DR AMINA ASGHAR +3
Substituted Naphthyridines and their use as Medicaments
UndeterminedPK201100053A0
Owner:BOEHRINGER INGELHEIM INT GMBH
Crystalline salts of a potent hcv inhibitor
UndeterminedPK201100158A0
Owner:BOEHRINGER INGELHEIM INT GMBH
Functionally effective organic molecules obtained by lignite
UndeterminedPK201100058A0
Owner:BIJAM BIOSCI
Hierarchical Multi-Persona AI Agent (HMPA) For Cyber Defense
PendingPK202600695A0
Owner:DANIYAL AFTAB MIRZA & ABEERA MEHTAB
A humanized immunoglobin which specifically binds beta amyloid peptide(AB)
UndeterminedPK141088A
Owner:JANSSEN ALZHEIMER IMMUNOTHERAPY & WYETH
Assembly of a dust fall particles collector from atmospheric air
UndeterminedPK141146A
Owner:AKHTER SHAREEF +4
Process For The Synthesis Of N-2-(7-Methoxy-1 Naphthyl)Ethyl]Acetamide (Agomelatine)
UndeterminedPK141151A
Owner:LES LAB SERVIER SA
A Process of Preparation of a biopesticide from Oscheius andrassyii an Entomopathogenic nematodes from Pakistan.
UndeterminedPK201100108A0
Owner:SHAHINA FAYYAZ +1
Acaricidal and / or insecticidal active ingredient combinations
UndeterminedPK201001088A0
Owner:BAYER CROPSCIENCE AG
Process for the removal of endocrine disrupting compound from an aqueous medium
UndeterminedPK141077A
Owner:OMYA DEV AG
Substituted 5-oxido-4-phenylsulphonyl-1,2,5 oxadiazol compound
UndeterminedPK141165A
Owner:LES LAB SERVIER SA
Pro-drugs of (e)-7-(3-(2-amino-1 fluoroethylidene)piperidin-1-yl)-1 cyclopropyl-6-fluoro-8-methoxy-4-oxo 1,4-dihydroquinoline-3-carboxylic acid
UndeterminedPK201100006A0
Owner:JANSSEN PHARMA NV
Use of 4‐phenylbutyric acid and / or salts thereof for enhancing stress tolerance in plants.
UndeterminedPK201100238A0
Owner:BAYER CROPSCIENCE AG
Process for the preparation of 3 difluoromethyl-1-methyl-1h-pyrazole-4 carboxylic acid (9-dichloromethylene 1,2,3,4-tetrahydro-1,4-methano-naphthalen 5-yl)-amide
UndeterminedPK201100655A0
Owner:SYNGENTA PARTICIPATIONS AG
Process for the preparation of 2-(cycloh exylmethyl)-n-{2-[(2s)-1-methylpyrrolidin-2yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7sulfonamide.
UndeterminedPK201100143A0
Owner:SANOFI AVENTIS SA
Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for administration shortly after amiodarone discontinuation
UndeterminedPK201100166A0
Owner:SANOFI AVENTIS SA
Substituted n-(arylalkyl)-1h-pyrrolopyridine-2 carboxamide compound
UndeterminedPK141164A
Owner:SANOFI AVENTIS SA
Selected inhibitors of protein tyrosine kinase activity.
UndeterminedPK201100255A0
Owner:METHYLGENE INC +1
A Composition Comprising A Vegf Receptor Inhibitor And A Penetration Enhancer
UndeterminedPK141155A
Owner:NOVARTIS AG
Processes and systems for the staged synthesis of alkyl bromides.
UndeterminedPK201100130A0
Owner:MARATHON GTF TECHNOLOGY LTD
Process for the preparation of isoxazoline derivatives.
UndeterminedPK201100118A0
Owner:SYNGENTA PARTICIPATIONS AG +1
Hydrate and anhydrous crystal form of the sodium salt of 2-iodo-N[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]benzenesulfonamide, Process for preparation thereof and use thereof as herbicides and Plant growth regulators.
UndeterminedPK201100111A0
Owner:BAYER CROPSCIENCE AG
A new cropping system for fodder production by using saline resources
UndeterminedPK141125A
Owner:M AJMAL KHAN +3
Thienopyrimidines containing a substituted alkyl groupfor Pharmaceutical Compositions.
UndeterminedPK201100124A0
Owner:BOEHRINGER INGELHEIM INT GMBH
Tryptamine derivatives as cytotoxic agents against tumor cell line hgc27 (gastric carcinoma cell)
PendingPK202600703A0
Owner:SABIRA BEGUM +5
Use of artificial zinc finger protein (AZP) and Fok-I nuclease for the resistance against cotton leaf curl disease
UndeterminedPK201100064A0
Owner:NAT INST FOR BIOTECHNOLOGY & GENETIC ENG (NIBGE)
Substituted 1h-imidazolyl pyrimidinylaminoethyl-2Methoxyacetamide compound
UndeterminedPK141091A
Owner:NOVARTIS AG
A pharmaceutically acceptable salt of aromatic boron-containing compound, method of making same and pharmaceutical composition thereof
PendingPK144872A
Owner:PROTOMER TECHNOLOGIES INC
A humanized immunoglobulin, or antigen-binding fragment thereof
UndeterminedPK141087A
Owner:JANSSEN ALZHEIMER IMMUNOTHERAPY & WYETH
Method for controlling plant parasitic nematodes through Oscheius niazii, an entomopathogenic nematodes.
UndeterminedPK201100107A0
Owner:SHAHINA FAYYAZ +1
Salts and Hydrates of 4-[(3-Chlor-4-Fluor-Phenyl)Amino]-6-(cis-4-{N-[(Morph-1-olin-4-yl)Carbonyl]-N-Methyl-Amino}-Cyclohexan-1-Yloxy)-7-Methoxy-Quinazoline, their use as a Medicament and the Preparation Threreof
UndeterminedPK201100089A0
Owner:BOEHRINGER INGELHEIM INT GMBH
Equol-containing fermented soybean hypocotyl material obtained by fermenting soyben hypocotyls using a microorganism
UndeterminedPK141129A
Owner:OTSUKA PHARM CO LTD
Two-for-one twisting or cabiling spindle
UndeterminedPK201100236A0
Owner:OERLIKON TEXTILE GMBH & CO KG
“Metered-dose inhaler actuator, metereddose inhaler and method of using the same”
UndeterminedPK201100641A0
Owner:CHIESI FARMACEUTICI SPA
A feed shaft for feeding particulate material to a mill
UndeterminedPK141126A
Owner:F L SMIDTH & CO AS
Tasted masked topiramate composition and an orally disintegrating tablet comprising the same
UndeterminedPK201100010A0
Owner:EURAND INC
A pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester of pyrimidyl sulphone amide compound
UndeterminedPK141184A
Owner:ASTRAZENECA AB
Tricyclic pyridine derivatives, medicaments containing such compounds, their uses and process for their preparation.
UndeterminedPK201100102A0
Owner:BOEHRINGER INGELHEIM INT GMBH
Polyherbal Formulation for the Control of Diabetes Mellitus and Method of Preparation Thereof
PendingPK144876A
Owner:MUDASSIR HASSAN +4
Over expressions of Biopharmaceuticals by using Bioinformatician technique Called as Relative Synonymous Codon Usage (RSCU)
UndeterminedPK201100079A0
Owner:DR ISHTIAQ QADRI +1
A pharmaceutical composition comprising N1 {3-fluoro-4-[(6(methyloxy)-7- {[3-(4-morpholinyl)propyl] oxy)-4-Quinolinyl)oxy]phenyl)- N1 -(4 fluorophenyl)-1,1Cyclopropanedicarboxamide
UndeterminedPK141082A
Owner:SMITHKLINE BEECHAM CORP
Treatment of keratinous fibers with an enzyme having perhydrolase activity.
UndeterminedPK201100132A0
Owner:DANISCO US INC
GPS Geofencing and Facial Recognition Based Faculty Attendance Management System
PendingPK202600717A0
Owner:ZARYAB MALIK
Pharmaceutical acceptable salts of Substituted Imidazoazepinone Compound
UndeterminedPK201100215A0
Owner:EISAI R&D MANAGEMENT CO LTD
Pesticidal solid composition containing cyclaniliprole or its salt
PendingPK144869A
Owner:ISHIHARA SANGYO KAISHA LTD
Aryl-and hetarylsulfonamides as active ingredients against abiotic plant stress
UndeterminedPK201100180A0
Owner:BAYER CROPSCIENCE AG
Method and device for heat recovery on a vapour refrigeration system
UndeterminedPK201100047A0
Owner:ECOLACTIS
Urban performance venue with integrated lagoon and spectator areas configured for optimal viewing
PendingPK144873A
Owner:CRYSTAL LAGOONS TECH INC
Use of Propineb for physiological curative treatment under zinc deficiency.
UndeterminedPK201100091A0
Owner:BAYER CROPSCIENCE AG
A process for preparation of iron sucrose complex based micronutrients foliar fertilizer
UndeterminedPK141136A
Owner:DR ARFA YASMIN CSO +1
Use of fluoroalkyl-substituted 2amidobenzimidazoles of the formula (I), or salts thereof.
UndeterminedPK201100139A0
Owner:BAYER CROPSCIENCE AG
A base or an acid addition salt of 3-substituted 3-benzofuranyl-indol-2-one, preparation thereof and therapeutic application thereof
UndeterminedPK201100085A0
Owner:SANOFI AVENTIS SA
Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases
UndeterminedPK201100159A0
Owner:SCHERING CORP
Preventing or reducing scale in wet process phosphoric acid production
UndeterminedPK201100212A0
Owner:CYTEE TECHNOLOGY CORP
Combination therapy for pancreatic cancer using an antigenic peptide and chemotherapeutic agent
UndeterminedPK141117A
Owner:ONCOTHERAPY SCI INC
Sustainable Bio-Generic Scaffold Integrating CuO / MgO Nano Engineered Hybrid for Efficient Phenol Remediation
PendingPK202600716A0
Owner:DR AMINA ASGHAR +4
A pharmaceutically acceptable salt of a compound comprising viral polymerase inhibitor for use in medicines.
UndeterminedPK201100239A0
Owner:BOEHRINGER INGELHEIM CANADA LTD
Biomarkers for midm2 inhibitors for use in treating disease.
UndeterminedPK201100248A0
Owner:THE RGT UNIV OF MICHIGAN
A Salt of Heterocycles substituted pyridine compound and antifungal agent containing thereof.
UndeterminedPK141161A
Owner:EISAI R&D MANAGEMENT CO LTD
Solid Pharmaceutical Composition with Enhancers and Methods of Preparing Thereof
UndeterminedPK201100052A0
Owner:MERRION RES III LTD
Determining optimization potentials of a direct current motor
UndeterminedPK201100656A0
Owner:SIEMENS AG
Substituted triazolo[4,5-b]pyridin-3-yl]-[4 (3- trifluoromethylphenyl)-piperazin-1 yl]methanone compound
UndeterminedPK141078A
Owner:SANOFI AVENTIS SA
A cytosolic Phospholipase A2 inhibitor compound for use in therapy
UndeterminedPK141114A
Owner:WYETH LLC